Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 165
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Quarterly Psychedelics Briefing: Q3 2026
Weekly Psychedelic Policy Briefing, September 21, 2026
Health Canada Authorizes Optimi’s Natural Psilocybin Trial as House Bill Targets Botanical Drug Exclusivity
Pα+ Psychedelic Bulletin #232: Q2’26 Psychedelic Lobbying Update; DEA Again Moves to Schedule 5 Tryptamines; Oregon Backpedals Psilocybin Fee Hike
Podcast: Psychedelics in D.C., FDA’s Framework, and New Zealand’s MDMA Prescribers
PT359 – Sawyer Hurwitz – Art, Philosophy, Sexuality, and “Psychedelics Tonight”
Psilocybin in the Treatment of Alcohol Use Disorder
Clearmind Announces Notice of Proposed Stock Consolidation
MYDECINE INNOVATIONS GROUP ANNOUNCES CLOSING UNDER SHARE SUBSCRIPTION AGREEMENT AND WELCOMES...
Clearmind Applies for Patent to Treat Obesity and Metabolic Syndrome
PT358 – Dr. Rick Barnett, Psy.D – Contexts of Use: Exploring...
Delix Therapeutics Expands World-Class Team with First Head of R&D
Numinus Expands Ketamine Therapy for Mental Health in Montreal and announces...
Psyence Group Completes Export of Psilocybin Mushrooms to Canada
Optimi Health, ATMA Journey Centers To Proceed With Phase I Natural...
Load more